Provided by Tiger Fintech (Singapore) Pte. Ltd.

Royalty Pharma plc

34.84
-0.4300-1.22%
Post-market: 34.860.0190+0.05%18:52 EDT
Volume:3.53M
Turnover:123.05M
Market Cap:14.68B
PE:14.21
High:35.38
Open:35.09
Low:34.72
Close:35.27
Loading ...
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

Major Issues Report

8-K - Current report
Mar 15, 2023

Major Issues Report

8-K - Current report
Feb 15, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 01, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 04, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 03, 2022

Major Issues Report

8-K - Current report